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302a Monday, February 22, 2010extent with 1.0 mM Ca2þ than control RyR2 (Po was 5X greater in diabetic
RyR2). Two weeks of insulin treatment blunted the enhanced Ca2þ responsive-
ness. When added to the cis chamber the potent reactive carbonyl species
(RCS), 80 mM methylglyoxal increased the open probability (Po) of RyR2 3-
fold (0.05 to 0.16) within 10 min and this increase was independent of holding
potential. Increasing [MGO] further to 160 mM, reduced the conductance of
RyR2 by 25% without changing Po. Incubating RyR2 with MGO (5-500 mM
with 200 mM free Ca2þ in buffer) dose-dependently reduced its ability to bind-
ing [3H]ryanodine. Singly mutating R1611, R2190 and K2888 to W or Y, to
mimic adducts previously found on them during diabetes, resulted in gain-of-
function of RyR2 (Po increased >2-fold at 3.3 mM Ca
2þ ). Mutating c-terminal
R4462, and R4683 toW or Y resulted in loss-of function of RyR2.We conclude
that modification of RyR2 by RCS during diabetes is responsible in part for its
dysregulation. (This work was funded by NIH and Nebraska Redox Biology
Center)
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Gating of the Purified Human Cardiac Ryanodine Receptor (hRyR2) in the
Absence of Regulatory Accessory Proteins
Saptarshi Mukherjee, Nia Lowri Thomas, Laila Guzadhur,
Chloe E. Maxwell, Alan J. Williams.
Cardiff University, Cardiff, United Kingdom.
The cardiac ryanodine receptor (RyR2) mediates Ca2þ efflux from intracellular
stores to effect myocyte contraction during excitation-contraction coupling.
Mutations in this channel perturb Ca2þ release function, leading to triggered
arrhythmias that may cause sudden cardiac death (SCD). The exact molecular
mechanisms by which SCD-linked RyR2 dysfunction occurs constitutes a bur-
geoning area of cardiac research. Most studies so far have concentrated on the
secondary effects of mutation on channel function by virtue of affecting chan-
nel modification by phosphorylation and accessory protein binding, with no
great emphasis on elucidating the gating mechanisms of the channel itself.
Our aim is to elucidate the mechanistic basis of wild-type (WT) hRyR2 activa-
tion by its primary activating ligand, Ca2þ, under precisely controlled condi-
tions in the absence of any accessory proteins with a view to determining the
effect of mutation on hRyR2 gating in the same way. hRyR2 channels, recom-
binantly expressed in HEK293 cells, were purified and studied at the single
channel level in symmetrical 210mM KCl under reducing conditions. Trans
(luminal) Ca2þ was buffered at 50nM using EGTA, while cis (cytosolic)
Ca2þ buffering was stringently controlled using EGTA, HEDTA and NTA to
achieve free Ca2þ concentrations in the range of 0-500 mM. Preliminary data
obtained from sigmoidal dose-response curves of Po vs pCa for 10 WT
hRyR2 channels yields an EC50 of 3.2551.04 mM, resulting in a maximum
Po greater than 0.8 (in 5 out of 10 channels). This increase in Po resulted
from an increase in the frequency of channel openings, until Po of 0.8 - above
which any increases in Po resulted from an increase in open times. Likely gating
mechanisms will be discussed with a view to mutant channel analysis.
Supported by the British Heart Foundation
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S-Adenosyl-L-Methionine Activation of Cardiac Ryanodinr Receptors is
Associated with an Increased Frequency of Subconductance Sates
Angela J. Kampfer, Edward M. Balog.
Georgia Institute of Technology, Atlanta, GA, USA.
The biological methyl group donor, S-adenosyl-L-methionine (SAM) activates
the cardiac ryanodine receptor (RyR2). Previously we investigated the mecha-
nism underlying SAM regulation of RyR2 with [3H]ryanodine binding to car-
diac SR vesicles. SAM enhances Ca2þ -activation of RyR2 and increases the
apparent affinity of ryanodine for the channel. Notably, methyltransferase in-
hibitors have no effect on SAM-activation, and SAM-mediated methylation
of RyR2 is not detected. Furthermore, the concentration dependence for
SAM and ATP-induced increase in [3H]ryanodine binding overlap. Presently,
we investigated the affect of SAM on native RyR2 channels incorporated
into planar lipid bilayers. Channel were grouped according to initial Po values
under control conditions (10 mM cytosolic Ca2þ), those with Po < 0.2 (n=7),
and Po > 0.2 (n=5). For channels with an initial Po < 0.2, SAM caused a rapid
(within seconds) increase in Po (p< 0.05). The SAM-induced increase in Po was
due primarily to an increase in mean open time (p<0.05; n¼3). Interestingly,
SAM activation was associated with an increased frequency of subconduca-
tance states. In contrast, the increase in channel Po caused by 2mM ATP
was not associated with the appearance of subconductance states. Thus, the ef-
fect on subconductance states appears specific to SAM. This work highlights
the complexity underlying SAM regulation of RyR2. The data suggest ligand
binding is among the multiple mechanisms responsible for SAM-activation
of RyR2.1575-Pos
Molecular Interplay between the Heart Lim Protein (HLP) and RyR2 in
Murine Heart
Dong Woo Song, So Yeon Park, Do Han Kim.
Gwangju Institute Science and Technology, Gwangju, Korea, Republic of.
HLP is a heart-specific LIM-only protein having two LIM domains each con-
sisting of two zinc fingers. Through the bacterial 2 hybrid screening and a fol-
lowing LC-MS/MS study, we have found that HLP interacts with the cytosolic
divergent region of mouse heart RyR2. The direct interaction between RyR2
and HLP was confirmed by GST pull-down and co-immunoprecipitation as-
says. HLP was partially co-localized with RyR2 in HL-1 cells and rat adult car-
diomyocytes. siRNA or Adenovirus-mediated knock-down of HLP in HL-1
cells and neonatal cardiomyocytes led to more than 70% decrease in the expres-
sion of HLP, without a concomitant change of other Ca2þ handling proteins
(e.g. SERCA, RyR2, calsequestrin and DHPR). Ca2þ transient measurement
of fura2-loaded cardiomyocytes by 1Hz field stimulation demonstrated that si-
lencing of HLP decreased the peak amplitude of Ca2þ transient (~ 15%) in HL-
1 cells and in neonatal cardiomyocytes. Currently, various deletion-mutants of
LIM protein are being used to characterize the RyR2 binding sites in HLP.
(This work was supported by the Korean Ministry of Science and Technology
grant, Systems Biology Research Grant, M1050301001-6N0301-0110, and the
2009 GIST Systems Biology Infrastructure Establishment Grant).
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Mitsugumin-29 Regulates RyR1 Activity In Mouse Skeletal Myotubes
Ji-Hye Hwang, Jin Seok Woo, Eun Hui Lee.
The Catholic Univ. of Korea, Seoul, Republic of Korea.
Canonical-type transient receptor potential cation channel type 3 (TRPC3) in
plasma membrane allows the entry of Ca2þ ions into various cells. In skeletal
myotubes, functional interaction between TRPC3 and RyR1 (ryanodine recep-
tor1, a Ca2þ channel in sarcoplasmic reticulum (SR) membrane) regulates the
gain of skeletal excitation-contraction coupling (J. Biol. Chem., 2006). Mitsu-
gumin-29 (MG29) is a four membrane-spanning protein and is found in both
plasma and SR membrane. MG29 has been known as a TRPC3-interacting pro-
tein in skeletal myotubes (Biochem. J., 2008).
To identify critical region(s) of MG29 that participate in binding to TRPC3 or
the role of MG29 in skeletal muscle, N-terminus, three intervenient loops
among four transmembrane regions, and C-terminus of MG29 were expressed
in E. coil as N-terminal GST-fused forms, and subjected to co-immunoprecip-
itation assay with intact TRPC3 from rabbit skeletal muscle. Cytoplasmic N-
terminus and a loop between first and second transmembrane domains of
MG29 effectively bound to TRPC3. Two deletion mutants of MG29 (missing
the TRPC3-binding sites: deleting the N-terminus only or longer N-terminus
covering the loop region) was expressed in mouse skeletal myotubes, and the
myotubes was subjected to the measurement of Ca2þ transients with Fura-2
or Fluo-4. The later mutant showed significantly decreased responsiveness of
RyR1 to caffeine, suggesting that MG29 may be a mediator between the func-
tional interaction between TRPC3 and RyR1.
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Phosphorylation of Excitation-Contraction Coupling Components in
a Guinea-Pig Model of Heart Failure
Mark L. Bannister1, Mark Scoote2, Martyn P. Kingsbury1, Mark A. Turner1,
Jolanda van der Velden3, Desmond J. Sheridan1, Alan J. Williams4,
Sian E. Harding1.
1Imperial College, London, United Kingdom, 2Colchester Hospital
University, Colchester, United Kingdom, 3VU University Medical Centre,
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Phosphorylation status appears to be a key determinant of excitation-contrac-
tion coupling ion channel and pump function. Dysfunction of the ryanodine re-
ceptor (RyR) secondary to catecholaminergic drive and phosphorylation has
been proposed as a factor in contractile dysfunction and arrhythmia patho-phys-
iology in the failing heart. The phosphorylation states of RyR, along with those
of phospholamban and troponin I have been investigated by immunoblotting,
and quantitated by comparing levels in failing hearts with basal levels, mini-
mum levels after beta-blocker treatment and maximal levels achieved by ex
vivo treatment with isoprenaline. We found that RyR residue Ser2809 was
phosphorylated to 124 5 11 % (n ¼ 5, P > 0.05) of control (sham-operated,
basal) in heart failure under basal conditions and 143 5 12 % (n ¼ 6, P <
0.05) with isoprenaline treatment, and residue Ser2030 was 94 5 10 % (n ¼
8, P > 0.05) for heart failure and 1995 9 % (n=6, P < 0.05) for isoprenaline
treatment. Phosphorylation levels at Ser16 of phospholamban were higher:
159 5 17 % (heart failure, n ¼ 7, P < 0.05) and 366 5 95 % (isoprenaline
treatment, n ¼ 5, P < 0.05). At Ser23/24 of troponin I there is no significant
Monday, February 22, 2010 303achange in heart failure (n ¼ 5, P < 0.05) but a 2305 92 % increase with iso-
prenaline treatment (n ¼ 6, P < 0.05). Basal levels of phosphorylation are thus
relatively low at RyR Ser2030, phospholamban Ser16, and troponin I Ser23/24,
and are not significantly increased in heart failure, but are substantially in-
creased by isoprenaline treatment. In contrast, the phosphorylation level at
Ser 2809 is already high and can be increased only moderately by isoprenaline.
1578-Pos
Inhibition of RyR2-S2814 Phosphorylation Prevents Heart Failure by
Reducing SR Ca Leak
Ralph J. van Oort, Na Li, Jonathan L. Respress, Angela DeAlmeida,
Xander H. Wehrens.
Baylor College of Medicine, Houston, TX, USA.
Abnormal regulation of RyR2 by Ca2þ/calmodulin-dependent protein kinase 2
(CaMKII) has been suggested as a cause of sarcoplasmic reticulum (SR) Ca2þ
leakage and contractile dysfunction in heart failure. We hypothesized that
CaMKII phosphorylation of RyR2 is crucial for heart failure development.
We generated RyR2 knockin mice in which CaMKII phosphorylation site
S2814 was mutated to alanine (S2814A) to prevent phosphorylation. Cardiac
function and dimensions monitored by echocardiography were similar in
S2814A and WT mice up to 12 months of age. WT (n=13) and S2814A
mice (n=9) were subjected to transverse aortic constriction (TAC) to induce
pressure overload. At 8 weeks after TAC, S2814A mice displayed a similar hy-
pertrophic response and decrease in ejection fraction (EF) as WT mice. At 16
weeks after TAC, however, EF was significantly lower in WT (32.5 þ/- 3.4%)
compared to S2814A mice (43.0 þ/- 2.9%) suggesting inhibition of heart fail-
ure development in the latter. This rescue effect was further verified by a lower
lung-weight-to-tibia-length ratio and a decrease in expression levels of the car-
diac stress genes ANF and BNP in S2814A mice compared to WT mice at 16
weeks after TAC. Ca2þ imaging in cardiomyocytes, isolated from S2814A and
WT mice at 16 weeks after sham or TAC surgery, demonstrated an decreased
incidence of spontaneous SR Ca2þ release (SCR) events in S2814A (29.7% of
myocytes) compared to WT (61.3% of myocytes; P<0.01). Whereas CaMKII
inhibitor KN93 reduced the incidence of SCR events in WT to 36.1% (P<0.01
vs. WT TAC), KN93 did not have an effect of SCR in S2814A myocytes
(30.0%; P=NS vs. S2814A TAC). Together, our results demonstrate that block-
ing CaMKII phosphorylation of RyR2 prevents SR Ca2þ leak, and inhibits or
delays the progression to congestive heart failure in S2814A mice.
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Luminal Regulation of Single RyR2 Channels by Cardiac Calsequestrin
Marcia Cortes-Gutierrez1, Heather R. Orrell1, Simon Williams2,
Patricio Velez1, Ariel L. Escobar1.
1UC Merced, Merced, CA, USA, 2TTUHSC, Lubbock, TX, USA.
We examined the hypothesis that calsequestrin (CSQ2) can regulate the RyR2
activity using a combination of single channel electrophysiology and lantha-
nide resonance energy transfer (LRET). Under steady-state, open probability
(Po) of RyR2 of cardiac SR fractions from dog is modulated by luminal
[Ca2þ]. Po increased when luminal [Ca2þ] was increased from 6 mM to
2 mM at a fixed cytosolic [Ca2þ] of 2 mM. This effect on RyR2 appears to
be mediated by luminal sites. Interestingly, RyR2 Po also increases when
2 mM Mg2þ was added to the luminal side. To gain mechanistic insights on
the Casq2-mediated luminal regulation, we used the binding of Casq2 to
Tbþ3 as a functional assay. Luminescence produced by LRET between the
tryptophan’s of purified dog Casq2 and the lanthanide increased as function
of the [Tbþ3]. This fluorescence was reduced as [Ca2þ] increased suggesting
that Ca2þ binds to purified Casq2 by displacing tightly bound Tbþ3 from
a common binding site. To further explore the specificity of this regulation,
we expressed recombinant dog Casq2 in E coli. The specificity of this interac-
tion was assessed by LRET lifetime measurements. Interestingly, we found that
the displacement of Tb3þ by Ca2þ was not significantly different than the dis-
placement of Tb3þ by Mg2þ (~ 2.5 mM) suggesting that Ca2þ and Mg2þ
share a common binding site. Finally, we explore the hypothesis that Tb3þ
bound to Casq2 was able to modulate the RR2 activity. At fixed cytosolic
[Ca2þ] of 2 mM, Po of single RyR2 increased as a function of luminal
[Tbþ3 (KD ~ 500 nM, Hill coeff. ~4). These results are consistent with the
idea that a multimeric form of Casq2 acts as luminal divalent cation sensor
and translates it into changes in RyR2 gating. Supported by NIH R01-HL-
084487 to AE.
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Ca SR Leak is Modulated by CaMKII Phosphorylation on RyR2-S2814
Yi Yang1, Laetitia Pereira1, Ralph J. van Oort2, Xander H.T. Wehrens2,
Donald M. Bers1.
1UC Davis, Davis, CA, USA, 2Baylor College of Medicine, Houston, TX,
USA.CaMKII has been shown to increase cardiac SR Ca leak through RyRs. RyR2-
S2814 has been suggested as the phosphorylation site responsible for SR Ca
leak triggering cardiac arrhythmias in heart failure. Here we test the require-
ment of S2814 for these effects, in knock-in mice expressing only RyR2-
S2814A or -S2814D. Ca spark frequency (CaSpF) and SR load were studied
in intact and permeabilized cardiomyocytes using confocal microscopy. At
baseline CaSpF is higher in S2814D vs. WT (8.750.4 (n=9) vs 6.4450.3,
n¼8, p<0.01) without altered SR Ca load. Activation of endogenous CaMKII
(1.2 mM Ca-calmodulin) in WT increases CaSpF as described by Guo et al
(Circ. Res, 2006), but only to the level seen in S2814D at baseline. Moreover,
CaMKII did not further increase CaSpF in S2814D myocytes. In RyR2-
S2814A CaMKII activation produces a very small CaSpF increase vs WT
(19 vs 60%), and that response in S2814A is secondary to increased SR Ca
load (by 15%, n¼10, p<0.01). In intact myocytes (as above), basal CaSpF
was highest in S2814D vs. WT and S2814A (which were similar). Baseline
Ca transients were not different among the groups. The cAMP activated GTP
exchange factor Epac may activate CaMKII to induce SR Ca leak (Pereira
et al, J Physiol, 2007). In WT mice the Epac activator 8-CPT enhanced CaSpF
and decreased both SR Ca load and Ca transient amplitude (consistent with
a primary effect on SR Ca leak). However, 8-CPT had no effect on any of these
parameters in either S2814A or S2814D myocytes. These data indicate that
RyR2-S2814 is the critical RyR2 site responsible for CaMKII-dependent en-
hancement of SR Ca leak and potential arrhythmogenesis in heart failure,
and confirm that Epac signaling can work through this same pathway.
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RyR2 NH2-terminal Mutations Associated with Cardiomyopathies Reduce
the Threshold for Ca2þ Release Termination
Yijun Tang.
Department of Physiology and Pharmacology, University of Calgary,
CALGARY, AB, Canada.
Naturally occurring mutations in the cardiac Ca2þ release channel/ryanodine
receptor (RyR2) have been linked not only to cardiac arrhythmias and sudden
death, but also to cardiomyopathies. The causal mechanisms underlying RyR2-
associated cardiomyopathies are unknown. We have previously shown that
RyR2 mutations linked to catecholaminergic polymorphic ventricular tachycar-
dia (CPVT) reduce the threshold for store overload induced Ca2þ release
(SOICR), also known as spontaneous Ca2þ release during Ca2þ overload.
To determine the impact of RyR2 mutations associated with cardiomyopathies,
we generated stable, inducible HEK293 cells expressing the RyR2 wt and the
exon-3 deletion, R420W, and L433P mutants, and monitored the luminal Ca2þ
dynamics in these wt and mutant cells using the fluorescence resonance energy
transfer (FRET)-based luminal Ca2þ sensing protein, D1ER. Consistent with
other CPVT mutations, the exon-3 deletion, R420W, and L433P mutations re-
duce the SOICR threshold. Interestingly, we found that these mutations also
lower the critical luminal Ca2þ level at which Ca2þ release is terminated
(the termination threshold). To further assess the role of the NH2-terminal re-
gion of RyR2 in Ca2þ release termination, we deleted the first NH2-terminal
305 amino acid residues and found that this NH2-terminal deletion also lowers
the termination threshold for Ca2þ release. Our data demonstrate that the NH2-
terminal region of RyR2 plays an important role in Ca2þ release termination,
and suggest that alterations in the termination of Ca2þ release via RyR2 may
cause cardiomyopathies (Supported by NIH and CIHR).
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Modulation of Neuroscretory Granule Mobilization and Neuropeptide
Release by Ryanodine Receptors in Neurohypophysial Terminals
Jose R. Lemos, Edward Custer, James McNally, Sonia Ortiz-Miranda.
Univ. of Massachusetts Medical School, Worcester, MA, USA.
The neuropeptides oxytocin (OT) and vasopressin (AVP) are contained in large
dense core vesicles (LDCV) and are released at the neurohypophysis (NH). The
mobilization and translocation of vesicles to exocytotic release sites is modu-
lated by cytosolic Ca2þ. Intracellular structures and organelles able to store
and release Ca2þ are significant contributors of cytosolic Ca2þ. The presence
of ryanodine receptors (RyR) in LDCV of NH terminals, coupled with the dem-
onstration that pharmacological activation of these receptors can induce spon-
taneous focal Ca2þ transients, make them ideal modulators of cytosolic levels
of Ca2þ, and therefore, vesicle mobilization and subsequent neuropeptide (NP)
release.
To test this hypothesis, the association of LDCV in an area within 0.45 mm of
the plasma membrane was assessed using immunolabeling of Neurophysin I
(OT) and II (AVP) along with high stringency deconvolution techniques in iso-
lated NH terminals. We found that the total amount of membrane associated
NP-immunoreactivity varies significantly between terminal type; significantly
higher in OT than in AVP terminals. This membrane associated distribution
